10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-030424`
Period End Date	20190630
Filing Date	20190808
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	tyme-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 24 Cash Flow Statement 39 Stockholders Equity 18

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.44M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$447.31K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$592.13K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$556.51K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.47M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.07K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.36K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$101.15K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$374.35K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$447.90K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$17.52M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total assets	`Assets`	$22.12M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	103.95M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	111.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	111.95M	shares	Point-in-time
Accounts payable and other current liabilities (including $377,000 and $325,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.69M	USD	Point-in-time
Accounts payable and other current liabilities (including $377,000 and $325,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.16M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$428.24K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$364.11K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$424.42K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.50M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$597.34K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$195.34K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$55.14K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.21M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.54M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.64M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$42.00K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$4.35M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.13M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.85M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 111,950,937 issued and outstanding at June 30, 2019, 300,000,000 authorized, 103,946,048 issued and outstanding at March 31, 2019	`CommonStockValue`	$10.40K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 111,950,937 issued and outstanding at June 30, 2019, 300,000,000 authorized, 103,946,048 issued and outstanding at March 31, 2019	`CommonStockValue`	$11.20K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$95.47M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$100.98M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-89.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.81M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.09M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.12M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.52M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$152.00K	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$400.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.72M	USD	1 Quarter
General and administrative (including $152,000 and $400,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.46M	USD	1 Quarter
General and administrative (including $152,000 and $400,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.71M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.18M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.72M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.72M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.18M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.94M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$80.24K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.63K	USD	1 Quarter
Interest expense	`InterestExpense`	$32.98K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-3.63K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$2.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.23M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.86M	shares	1 Quarter

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.19M	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.72M	USD	1 Quarter
Depreciation	`Depreciation`	$2.37K	USD	1 Quarter
Depreciation	`Depreciation`	$1.30K	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$2.34M	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$1.62M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.94M	USD	1 Quarter
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$525.97K	USD	1 Quarter
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-144.83K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$54.82K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-445.38K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingAssets`	$-73.55K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-528.77K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-99.42K	USD	1 Quarter
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-156.03K	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.25M	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.07M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLiabilities`	$-6.85K	USD	1 Quarter
Net cash provided by (used in) operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-6.31M	USD	1 Quarter
Net cash provided by (used in) operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-5.60M	USD	1 Quarter
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	1 Quarter
Insurance note payments	`InsuranceNotePayments`	$210.77K	USD	1 Quarter
Insurance note payments	`InsuranceNotePayments`	$402.00K	USD	1 Quarter
Proceeds from underwritten registered offering, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$11.17M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-210.77K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.77M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.16M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-6.54M	USD	1 Quarter
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$19.47M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$22.44M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$19.47M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$22.44M	USD	Point-in-time
Interest	`InterestPaidNet`	$3.63K	USD	1 Quarter
Interest	`InterestPaidNet`	$32.98K	USD	1 Quarter

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$22.09M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	111.95M	shares	Point-in-time
Issuance of common stock from underwritten registered offering, net of associated expenses of $111,227	`StockIssuedDuringPeriodValueNewIssues`	$3.89M	USD	1 Quarter
Issuance of common stock from underwritten registered offering, net of associated expenses (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	8.00M	shares	Point-in-time
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.62M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$22.09M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	111.95M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.